ROSA CLEAVER: Open Payments
NPI 1225508377 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 5 payments from 5 companies in 2025. Trend: 2023 $78 · 2024 $109 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $110 |
| Xeris Pharmaceuticals, Inc. | 1 | $60 |
| Dexcom, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, GVOKE HYPOPEN, Dexcom G6 Transmitter, MOUNJARO, VRAYLAR.
Industry payments across OH — which companies pay providers there.
